Valutazione del dolore postoperatorio dopo l'utilizzo di sigillanti a base di resina e bioceramici in molari mandibolari con periodontite apicale asintomatica
Valutazione dell'effetto dei sigillanti a base di resina e bioceramici sul dolore postoperatorio nei molari mandibolari con periodontite apicale asintomatica trattati in un'unica seduta
The goal of this clinical trial is to compare two root canal sealers in adults who need root canal treatment of a lower back tooth (mandibular first or second molar) with a dead (necrotic) pulp and no pain before treatment. The main question it aims to answer is: Does the type of sealer used to fill the root canals affect pain after single-visit root canal treatment?
Researchers compared a calcium silicate-based sealer (BioRoot RCS) with an epoxy resin-based sealer (AH Plus).
Participants:
Received root canal treatment completed in a single visit, with canals filled using the cold lateral compaction technique and one of the two sealers, assigned at random Recorded their pain on a 100 mm visual analog scale at 6, 12, and 24 hours and on days 2, 3, 5, and 7 after treatment Recorded whether, when, and how much pain medication (ibuprofen) they took during the 7-day follow-up
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Intervento / Trattamento
Intervento / Trattamento
Descrizione dettagliata
This single-center, parallel-group randomized controlled trial was conducted at the Department of Endodontics, Faculty of Dentistry, Atatürk University (Erzurum, Türkiye). Seventy patients with a mandibular first or second molar with pulp necrosis and either normal apical tissues or asymptomatic apical periodontitis (periapical index score ≤ 3), without preoperative pain, were randomly allocated in a 1:1 ratio to the BioRoot RCS group or the AH Plus group (35 per group).
All treatments were performed in a single visit by one operator following a standardized protocol. Canals were shaped with the WaveOne Gold reciprocating system and irrigated with 2.5% sodium hypochlorite, followed by final irrigation with 17% EDTA, 2.5% sodium hypochlorite, and saline. Allocation was concealed in sequentially numbered, opaque, sealed envelopes opened immediately before obturation. In both groups, canals were obturated by cold lateral compaction, and the teeth were permanently restored in the same visit.
The primary outcome was postoperative pain intensity on a 100 mm visual analog scale at 6, 12, and 24 hours and on days 2, 3, 5, and 7. The secondary outcome was the proportion of participants who used rescue analgesics (ibuprofen 400 mg) during the 7-day follow-up.
Tipo di studio
Tipo di studio
Iscrizione (Effettivo)
Iscrizione
Fase
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
palandöken
-
Erzurum, palandöken, Turchia (Türkiye), 25100
- Atatürk University Faculty of Dentistry
-
-
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Age 18-65 years
- American Society of Anesthesiologists (ASA) physical status I
- Mandibular first or second molar with complete root formation and no previous endodontic treatment
- Pulp necrosis (no response to cold and electric pulp tests), confirmed clinically by the absence of bleeding in the pulp chamber during access cavity preparation
- Normal apical tissues or asymptomatic apical periodontitis according to the American Association of Endodontists diagnostic terminology (periapical index score of 3 or less)
- No spontaneous pain and no tenderness to percussion or palpation before treatment
- No analgesic intake within the previous 72 hours and no antibiotic intake within the previous month
- Written informed consent
Exclusion Criteria:
- Systemic disease, immunodeficiency, or regular medication use
- Pregnancy
- Known allergy to the materials or drugs used in the study
- Symptomatic apical periodontitis, acute apical abscess, or chronic apical abscess
- Swelling or sinus tract
- Periodontal probing depth greater than 3 mm
- Root canal calcification, internal or external root resorption, or open apex
- Teeth requiring a post-and-core restoration
- Periapical index score greater than 3
- Bleeding in the pulp chamber during access cavity preparation (pulp necrosis not confirmed)
- Two canals in the distal root
- Treatment that could not be completed in a single visit or that required intracanal medication
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Doppio
Numero di armi
Armi e interventi
Gruppo di partecipanti / ArmGruppo di partecipanti / Arm |
Intervento / TrattamentoIntervento / Trattamento |
|---|---|
|
Sperimentale: BioRoot RCS Group
Single-visit root canal treatment of mandibular molars with pulp necrosis; canals obturated by cold lateral compaction using the calcium silicate-based sealer BioRoot RCS. |
Single-visit root canal treatment of mandibular first or second molars with pulp necrosis and either normal apical tissues or asymptomatic apical periodontitis (PAI ≤ 3). Canals were shaped with the WaveOne Gold reciprocating system, irrigated with 2.5% NaOCl, and finally irrigated with 17% EDTA, 2.5% NaOCl, and saline. Canals were obturated by cold lateral compaction using gutta-percha cones and the calcium silicate-based sealer BioRoot RCS (Septodont). No intracanal medication was used. |
|
Comparatore attivo: AH Plus Group
Single-visit root canal treatment of mandibular molars with pulp necrosis; canals obturated by cold lateral compaction using the epoxy resin-based sealer AH Plus. |
Single-visit root canal treatment of mandibular first or second molars with pulp necrosis and either normal apical tissues or asymptomatic apical periodontitis (PAI ≤ 3). Canals were shaped with the WaveOne Gold reciprocating system, irrigated with 2.5% NaOCl, and finally irrigated with 17% EDTA, 2.5% NaOCl, and saline. Canals were obturated by cold lateral compaction using gutta-percha cones and the epoxy resin-based sealer AH Plus (Dentsply DeTrey). No intracanal medication was used. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Postoperative pain intensity
Lasso di tempo: 6, 12, and 24 hours and 2, 3, 5, and 7 days after treatment
|
Postoperative pain intensity was self-recorded by participants on a 100 mm visual analog scale (VAS), where 0 mm indicates no pain and 100 mm indicates the worst imaginable pain. VAS scores were categorized as no pain (0-4 mm), mild (5-34 mm), moderate (35-64 mm), severe (65-85 mm), and very severe pain (86-100 mm), and the groups were compared at each time point. |
6, 12, and 24 hours and 2, 3, 5, and 7 days after treatment
|
Misure di risultato secondarie
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Proportion of participants using analgesics
Lasso di tempo: From the end of treatment to day 7 after treatment
|
Proportion of participants in each group who took rescue analgesic medication (ibuprofen 400 mg, taken only in case of severe pain) during the follow-up period, as self-recorded on the pain record form together with the time and dose of each intake. |
From the end of treatment to day 7 after treatment
|
Collaboratori e investigatori
Sponsor
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Inizio studio
Completamento primario (Effettivo)
Completamento primario
Completamento dello studio (Effettivo)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- B.30.2ATA.0.01.00/559
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .